Additional file 2: of A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment

Jacqueline Whang-Peng (Creator)
Yu Chen Wu (Creator)
Tsu-Yi Chao (Contributor)
Woei Yau Kao (Contributor)
Ko Jiunn Liu (Contributor)
Ann Lii Cheng (Contributor)
Hui Ju Ch'ang (Contributor)
T. R. Chung (Contributor)
Jang Yang Chang (Contributor)
Wei Lan Yu (Contributor)

Dataset

Description

The results of T cell proliferation assay. (XLS 93Â kb)

Date made available	2016
Publisher	Figshare

DOI
10.6084/m9.figshare.c.3612833_d1.v1

Access Dataset

CC BY + CC0

1 Article

A phase i clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment John T Kung
Liu, K. J., Chao, T. Y., Chang, J. Y., Cheng, A. L., Ch'Ang, H. J., Kao, W. Y., Wu, Y. C., Yu, W. L., Chung, T. R. & Whang-Peng, J., Aug 24 2016, In: Journal of Biomedical Science. 23, 1, 64.
Research output: Contribution to journal › Article › peer-review

Open Access
24 Link opens in a new tab Citations (Scopus)

Cite this

DataSetCite

Whang-Peng, J. (Creator), Wu, Y. (Creator), Chao, T. (Contributor), Kao, W. (Contributor), Liu, K. (Contributor), Cheng, A. (Contributor), Ch'Ang, H. (Contributor), Chung, T. (Contributor), Chang, J. (Contributor), Yu, W. (Contributor) (2016). Additional file 2: of A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment. Figshare. 10.6084/m9.figshare.c.3612833_d1.v1

Additional file 2: of A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment

Description

DOI

Access Dataset

Research output

A phase i clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment John T Kung

Cite this